LNSR
LENSAR, Inc.
Medical Devices · Healthcare · United States
5.84
close · 2026-10-30
value
21
cheaper than peers21
quality
98
stronger fundamentals98
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.19× | 77 |
| cash flow yield, 1 year ago | -3.4% | 52 |
| earnings yield, 2 years ago | -22.4% | 36 |
| cash flow yield, 2 years ago | -13.8% | 36 |
| price to book | 4.81× | 32 |
| earnings yield, 3 years ago | -33.6% | 28 |
| cash flow yield, 3 years ago | -20.9% | 27 |
| earnings yield, 1 year ago | -46.7% | 25 |
| cash flow yield, latest year | -20.8% | 22 |
| earnings yield, latest year | -49.1% | 19 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 357.3% | 99 |
| operating margin | 12.9% | 82 |
| debt to equity | 8.3% | 79 |
| revenue growth | 18.4% | 73 |
4 of 4 measures available
Facts
| market cap | $72M |
| free cash flow | -$24.4M |
| employees | 150 |
| first trade | 2020-10-02 |
| next earnings | 2026-08-13 |
| fundamentals updated | 2026-08-20 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -2.87 | -2.73 | -1.31 | -1.96 |
| free cash flow | -$14.9M | -$2.4M | -$9.9M | -$15.0M |
| net income | -$34.3M | -$31.4M | -$14.4M | -$19.9M |
| revenue | $58.4M | $53.5M | $42.2M | $35.4M |
| unusual items | -$10.3M | -$25.1M | -$2.9M | not reported |